Cassava Sciences GAAP EPS of -$0.92

Posted on by wpadmin
  • Cassava Sciences press release (NASDAQ:SAVA): Q2 GAAP EPS of -$0.92.
  • Cash and cash equivalents were $112.4 million, with no debt, as of June 30, 2025. This compares to cash and cash equivalents of $128.6 million as of December 31, 2024.

Leave a Reply

Your email address will not be published. Required fields are marked *